Tandem Diabetes Rg
TNDM
USD
STOCK MARKET:
NMS
Closed
 
...
Large gap with delayed quotes
Last quote
04/25/2026 - 02:00:00
Bid
04/27/2026 - 15:00:03
Bid
Volume
Ask
04/27/2026 - 15:00:03
Ask
Volume
20.36
-0.32 ( -1.55% )
20.20
100
21.00
1,000
More information
Analysis by TheScreener
24.04.2026
Evaluation Slightly negative  
Interest Weak  
Sensibility High  
Analysis date: 24.04.2026
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 31.03.2026.
Interest
  Weak
Two stars since 27.03.2026.
Earnings Rev Trend
  0.10
 
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is positive since 06.02.2026 at a price of 19.17.
Evaluation
  Strongly undervalued
 
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
  Negative
 
The dividend-adjusted forty day technical trend is negative since 27.03.2026.
4wk Rel Perf
  -26.22%
 
The four-week dividend-adjusted underperformance versus SP500 is 26.22%.
Sensibility
  High
High, no change over 1 year.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 4.71%.
Mkt Cap in $bn
  1.39
With a market capitalization <$2bn, TANDEM DIABETES CARE is considered a small-cap stock.
G/PE Ratio
  1.59
A "Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings" ratio higher than 1.5 indicates that the stock's price presents a discount to growth >40% in this case.
LT P/E
  27.47
The estimated PE is for the year 2028.
LT Growth
  43.70%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
  18
Over the last seven weeks, an average of 18 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  136
For 1% of index variation, the stock varies on average by 1.36%.
Correlation
  0.23
Stock movements are strongly independent of index variations.
Value at Risk
  11.66
The value at risk is estimated at USD 11.66. The risk is therefore 57.25%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  05.07.2019